The RTICC Fellowship, backed by the Rappaport and Azrieli Foundations, is dedicated to fostering cutting-edge research that combines basic science, clinical oncology, and engineering. It provides crucial funding to PhD students, postdoctoral fellows, and physicians. This initiative reflects RTICC’s commitment to advancing cancer research through multidisciplinary collaboration and innovation.

The fellowship's goal is to empower the next generation of scientists and physicians by encouraging research that crosses traditional boundaries. Priority is given to projects that demonstrate a multidisciplinary approach and are co-supervised by principal investigators from different Technion faculties and affiliated hospitals. Each selected researcher receives significant financial support to drive forward their impactful studies, with the fellowship ensuring continuity for up to three years.

The 2024-2025 RTICC Fellowship recipients and their research topics are as follows:

Post Doctoral Fellow Julia Belansky: “Linking Lynch Syndrome Mutations to the Gut Microbiome profile: A Predictive Approach for Colorectal Cancer Risk”.

Supervisors: Prof. Naama Geva Zatorsky, Rappaport Faculty of Medicine; Prof. Elizabeth Half, Rambam Health Care Campus.

Post Doctoral Fellow Rawan Bassal: “Heparanase-2 (Hpa2) based therapy against cancer and inflammation”.

Supervisors: Prof. Israel Vlodavsky, Rappaport Faculty of Medicine; Prof. Fabian Glaser, Technion Center for Structural Biology.

Dr. Chen Buxbaum-Ephrat: “Developing a novel approach to the current neuroblastoma research by using a more appropriate age-related neuroblastoma model in mice”.

Supervisors: Prof. Yuval Shaked, Rappaport Faculty of Medicine; Prof. Shifra Ash, Rambam Health Care Campus.

Binyamin Perets: “Sample-Centric Insights into Dynamic Biological Networks: A Novel Statistical Approach Leveraging Mutual Information Graphs”.

Supervisors: Prof. Shai Shen-Orr, Rappaport Faculty of Medicine; Prof. Shie Mannor, Faculty of Electrical and Computer Engineering.

Ghazal Kheshaiboun: “Molecular Basis for Oncogenic Translation in Melanoma.”

Supervisors: Prof. Amir Orian, Rappaport Faculty of Medicine; Prof. Emily Avitan-Hersh, Rambam Health Care Campus.

Alma Sophia Barisaac: “Targeting RBM10 deficiency in lung adenocarcinoma with small molecule drugs”.

Supervisor: Prof. Nabieh Ayoub, Faculty of Biology.